Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
The funding is inted boost company's siRNA Portfolio.
Lead Product(s): RB-RQ007
Therapeutic Area: Ophthalmology Product Name: Undisclosed
Highest Development Status: PreclinicalProduct Type: Large molecule
Partner/Sponsor/Collaborator: Capital Venture Capital Fund
Deal Size: $66.0 million Upfront Cash: Undisclosed
Deal Type: Series C Financing April 06, 2020